MedPath

Strong saline - the effect of repeating doses

Conditions
Elevated eyepressure
MedDRA version: 16.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disorders
MedDRA version: 16.0Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disorders
Therapeutic area: Diseases [C] - Eye Diseases [C11]
Registration Number
EUCTR2013-001733-41-FI
Lead Sponsor
Harju Mika
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
26
Inclusion Criteria

Open angle glaucoma and ocular hypertension patients with intraocular pressure 22-34 mmHg
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 13
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 13

Exclusion Criteria

Ödemin medication, age under 25 years, age higher than 80 years, kidney failure, heart failure, dementia, other medical disorder that affects significantly patients condition

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Change in eyepressure in two different groups: total dose 1 mmol/kg and two doses of 0.5 mmol/kg between 10 minutes;Secondary Objective: Blood pressure, pulse;Primary end point(s): Eyepressure aften one 1 mmol/kg 23,4% NaCl or after two repeating doses of 0.5 mmol/kg 23,4% NaCl;Timepoint(s) of evaluation of this end point: 20 minutes in 1.0 mmol/kg group and 30 minutes in 0.5 mmol/kg x2 group
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Eyepressure aften one 1 mmol/kg 23,4% NaCl or after two repeating doses of 0.5 mmol/kg 23,4% NaCl;Timepoint(s) of evaluation of this end point: 1.0 mmol/kg group: 0, 3, 6, 13, 10, 13 and 16 minutes. <br>0.5 mmol/kg x2 group: 0, 3, 6, 10, 13, 16, 20, 23 and 26 minutes.
© Copyright 2025. All Rights Reserved by MedPath